Ignite Creation Date:
2024-07-17 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498921
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
22743
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None